Case 1, a high-risk idiopathic membranous nephropathy patient
High-risk idiopathic membranous nephropathy, confirmed by renal biopsy and anti-PLA2R antibody testing
He or she received Huaier Granules, an herbal extract product, together with renin-angiotensin system inhibitor drugs (RASi) as the base treatment. After more than a year, the anti-PLA2R antibody became negative and the urine protein, blood albumin, and kidney filtering rate all improved. The report does not give the exact lab numbers.
In one high-risk membranous nephropathy patient, adding Huaier Granules to standard blood-pressure drugs was followed by the disappearing of the key antibody and full clinical remission over 25 months.
- This is a single patient (Case 1) inside a two-person case series, not a trial.
- After more than 12 months, the anti-PLA2R antibody turned negative and urine protein, blood albumin, and kidney filtering rate (eGFR) all improved versus the starting point.
- Case 1 reached complete clinical remission and was followed for 25 months; the other patient reached partial remission and was followed for 21 months.
- The treatment was Huaier Granules plus renin-angiotensin system inhibitor drugs (RASi), with the RASi as the base therapy.
- No obvious side effects tied to Huaier Granules were seen, and the patients tolerated it well.
Why it might work
The paper points out that several accepted membranous nephropathy drugs, like cyclophosphamide and rituximab, were first built to treat cancer, and Huaier Granules is a plant extract already used against tumors. The authors' idea is that this same anti-tumor product might calm the immune attack behind membranous nephropathy, letting the anti-PLA2R antibody fall to negative and the leaky kidney filter heal enough to lower urine protein and lift blood albumin. The paper frames this only as a possible new add-on strategy, not a proven one.
The honest limits
- This is n=1 within a two-patient case series, so it cannot show the drug caused the improvement rather than time or the RASi base treatment.
- The abstract gives no exact lab numbers for antibody level, 24-hour urine protein, albumin, or eGFR, so the size of the change is unknown.
- eGFR is an estimate of kidney function, not a direct measurement.
- The abstract shows no disclosure of conflicts of interest, even though Huaier Granules is a commercial product, and there was no control group.
- Is my membranous nephropathy tied to a positive anti-PLA2R antibody, and is a RASi already the right base treatment for me?
- Given this is based on only one or two patients with no exact numbers, is there any real evidence Huaier Granules would help my stage 3 kidney disease?
- Could an herbal product like this interfere with my current medicines or my kidney function?